Saturday June 19, 2021 - 10:00AM PT
Jeremie Calais MD MSc - PSMA theranostics
Dr. Jeremie Calais is Assistant Professor and Director of the Clinical Research Program of the Ahmanson Translational Theranostics Division of the Department of Molecular and Medical Pharmacology at UCLA and is one of the leading prostate cancer imaging and theranostics researchers
MAY 15 2021 - 10:00AM PT
Bernadette Greenwood
Update 2021 - Imaging based prostate cancer management
BERNADETTE GREENWOOD MSC., PG CERT., RT(R)(MR)(ARRT) CHIEF RESEARCH OFFICER AT HALODX CLINICAL INSTRUCTOR, DEPARTMENT OF INTERNAL MEDICINE UC RIVERSIDE SCHOOL OF MEDICINE.
Bernadette gave an update on oncologic imaging and prostate MRI and MR-guided intervention.
Read her Bio here
November 21, 2020 - 10:00am PT
Dr.Richard Lam
GENETIC TESTING IN PROSTATE CANCER
A double board-certified internist and oncologist, Richard Lam, MD, has been specializing full time at Prostate Oncology Specialists in the treatment of prostate cancer since 2001.
Dr. Lam discussed genetic testing and how it's being applied for prostate cancer research, diagnosis and treatment.
As always, his presentations was very informative and presented in an easily understood format. He also brought a great wit with a touch of humor.
October 17, 2020 - 10:00am PT
Dr.Carl Rossi and Dr. Einck
Advances in Proton Therapy
Carl Rossi, MD, radiation oncologist and Medical Director of the California Proton Treatment Center has personally treated more than 10,000 prostate cancer patients with proton radiation over the last 26 years—more than any other physician in the world.
John P. Einck, MD, Radiation Oncologist and Professor of Radiation Medicine and Applied Sciences believes in a team-based approach to patient care. Dr. Einck joined California Protons Cancer shortly after the center’s opening in 2014. His treatment philosophy emphasizes patient education and encourages everyone to participate in deciding what course of treatment is best for them and their personal goals.
september 19, 2020 - 10:00AM PT
Dr. Sumit Subudhi - Oncology and Immunology
Dr. Sumit Subudhi is a medical oncologist and immunologist whose research focuses on the mechanisms and pathways within the immune system that are responsible for tumor rejection.
Dr. Subudhi’s work includes examining the effects of targeting immune checkpoints (e.g., CTLA-4 and PD-1) in prostate cancer and continuing to uncover the mechanisms that tumors use to evade the immune system.
==================
Due to COVID-19, no in-person meetings will be held at the Sanford Burnham Prebys Medical Discovery Institute until further notice.